Specialist urologists should handle vasectomy reversal cases, says 10-year study

Vasectomy reversals should be carried out by urology specialists with access to appropriate micro-surgical training and assisted reproductive technologies and not general urology surgeons, according to research published in the October issue of BJUI.

The findings are based on a series of surveys carried out among consultant members of the British Association of Urological Surgeons (BAUS) over a ten-year period.

"It is clear from our research that couples should not be seen by urologists with diverse interests, but by those with appropriate knowledge of all of the factors influencing the outcome of a reversal" says co-author and consultant urologist Dr Stephen R Payne from Manchester Royal Infirmary, UK.

"Patient management after previous vasectomy is a complex process requiring detailed knowledge when it comes to the surgical techniques available and the options for maximising the chance of any subsequent pregnancy."

BAUS members were surveyed in 2001, 2005 and 2010, with a total of 835 replies to the three questionnaires and an overall response rate of 47%.

Every year some 20,000 vasectomies are performed in the UK. During the procedure, the vas deferens, the ducts that carry sperm from the testicles to the seminal vesicles, are cut and tied to interrupt sperm flow.

About 6% of men subsequently ask for the procedure to be reversed so that their partner can get pregnant. Various options are available to these couples, including vaso-vasostomy, a surgical reversal procedure where the ends of the vasa are identified and joined back together again. The other options are surgical retrieval of sperm, which then need to be used together with IVF, and the use of donated sperm or adoption.

The overall findings of the surveys showed that:

  • more than 80% of respondents performed vaso-vasostomy, but about three-quarters were only doing 15 or less procedures a year
  • only 50% of urologists counselled couples about alternatives to vasectomy reversal
  • less than half (41%) gave patients details on their personal outcomes for vaso-vasostomy.
However, the 2010 audit showed that members of the BAUS section of andrology, who specialise in problems relating to the male genital tract, were more likely than non-members to:
  • perform more than 15 vaso-vasotomies a year (25% versus 4%)
  • insist on seeing both partners (85% versus 80%)
  • discuss all options for parenting in detail (63% versus 44%)
  • be fully conversant with the criteria for in-vitro fertilisation (54% versus 23%)
  • provide their individualised information about expected outcome (86.5% versus 71%)
  • routinely retrieve sperm when carrying out a vaso-vasostomy (18% versus 10%)
  • use an operating microscope (40% versus 26%).
"The latest data showed significant differences between BAUS members with an andrological affiliation and those without, when it came to their ability to discuss options for having a child and local eligibility criteria for IVF treatment, give individualised outcomes from vasectomy reversal and perform a larger number of procedures" says Dr Payne.

"It can be inferred from these results that surgeons with an andrological sub-specialist interest give a more balanced view of the options couples might consider when counselling men presenting for .

"Further sub-analysis suggests that quality improves as surgeons handle an increased number of case each year. Although our data suggests a trend that quality improves after 15 procedures per year, a prospective study is required to determine the relationship between outcome measures, such as live birth rates, and annual case volume."

More information: UK practice regarding reversal of vasectomy 2001: relevance to best contemporary patient management. Grey et al. BJUI. 110, pp1040. (October 2012). doi:10.1111/j.1464-410X.2011.10853.x

add to favorites email to friend print save as pdf

Related Stories

Contraception: progress brings hope for new methods for men

Sep 28, 2007

For decades, pundits have predicted new contraceptives for men within the next 5 to 10 years. Are we really getting any closer? Judging from work presented today at the second "Future of Male Contraception" conference, ...

Recommended for you

Hormonal therapy for transsexualism safe and effective

10 hours ago

Hormonal therapy for transsexual patients is safe and effective, a multicenter European study indicates. The results will be presented Saturday at The Endocrine Society's 95th Annual Meeting in San Francisco.

Royalty Pharma lets Elan takeover bid expire

14 hours ago

Royalty Pharma has let its latest takeover bid for Irish drugmaker Elan lapse as it decided against pressing ahead with a court challenge of a requirement that it withdraw the offer.

FDA approves new silicone breast implants

Jun 17, 2013

(HealthDay)—MemoryShape breast implants have been approved by the U.S. Food and Drug Administration for breast augmentation in women 22 and older, and for breast reconstruction, the FDA said Friday.

User comments

More news stories

Study suggests new approach to fight lung cancer

Recent research has shown that cancer cells have a much different – and more complex – metabolism than normal cells. Now, scientists at The University of Texas at Dallas have found that exploiting these differences might ...

Getting enough sleep could help prevent type 2 diabetes

Men who lose sleep during the work week may be able to lower their risk of developing Type 2 diabetes by getting more hours of sleep, according to Los Angeles Biomedical Research Institute (LA BioMed) research findings presented ...

Aspirin may fight cancer by slowing DNA damage

Aspirin is known to lower risk for some cancers, and a new study led by a UC San Francisco scientist points to a possible explanation, with the discovery that aspirin slows the accumulation of DNA mutations in abnormal cells ...